课题基金 / 基金详情

ALTERED SUBSTRATE PREFERENCE IN REPERFUSED HEARTS

ALTERED SUBSTRATE PREFERENCE IN REPERFUSED HEARTS
再灌注心脏中底物偏好的改变
批准号:
6184006
负责人:
PAUL E WOLKOWICZ
金额:
$19.88万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-01 至 2002-06-30

项目摘要

项目成果

PAUL E WOLKOWICZ的其他基金

相似基金

相关文献

中文摘要
翻译
描述(改编自申请人摘要):本申请
英文摘要
DESCRIPTION (Adapted from Applicant's Abstract): This application investi-gates a marker of viability in post-ischemic hearts, altered substrate preference. Hearts normally use exogenous long-chain fatty acids (LC-FA) as the preferred substrate for energy production. LC-FA also may be stored as triglycerides (TG) but storage of LC-FA occurs at a low rate in normal hearts. As a result, the TG content of normal hearts is low. Oxidation of alternate substrate, such as glucose also is low in normal hearts. Viable post-ischemic myocardium demonstrates a pattern of substrate preference different from normal hearts. Specifically, oxidation of glucose and storage of LC-FA, a glycolysis-dependent process, are enhanced. These changes increase the content of TG in viable post-ischemic myocardium, an event that has been reported by histological, radionuclide, tomographic and magnetic resonance imaging analyses. Despite the fact that enhanced LC-FA storage is one hallmark of viable post-ischemic myocardium, little is known about the relationship between LC-FA storage and altered substrate preference in post-ischemic myocardium. Also, the underlying cause(s) of altered substrate preference in post-ischemic myocardium is not known. Consequently, the application has two goals. The first goal is to quantitate thoroughly the altered substrate preference in isolated post-ischemic rat hearts using 13C-magnetic resonance spectroscopy and radionuclide technologies. The second goal is to determine the underlying cause(s) for altered substrate preference using enzymatic analyses. Accomplishing these goals will delineate the mechanism and importance of enhanced LC-FA storage as a marker for myocardial viability in post-ischemic hearts.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Fasudil prevents KATP channel-induced improvement in postischemic functional recovery.
Fasudil 可防止 KATP 通道诱导的缺血后功能恢复改善。
DOI: 10.1152/ajpheart.00611.2004
发表时间: 2005
期刊: American journal of physiology. Heart and circulatory physiology
影响因子: --
作者: [Nishizawa,Kenya, Wolkowicz,PaulE, Yamagishi,Tadashi, Guo,Ling-Ling, Pike,MartinM]
通讯作者: Pike,MartinM
Activation of leptin expression by an inhibitor of carnitine palmitoyltransferase-1.
肉碱棕榈酰转移酶 1 抑制剂激活瘦素表达。
DOI: 10.1038/sj.ijo.0802585
发表时间: 2004
期刊: International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity
影响因子: --
作者: [Wolkowicz,P, Grenett,H, Belousova,M, Urthaler,F]
通讯作者: Urthaler,F
1H-MRS detected lipolysis in diabetic rat hearts requires neutral lipase.
1H-MRS检测到糖尿病大鼠心脏中的脂肪分解需要中性脂肪酶。
DOI: 10.1081/jcmr-100000141
发表时间: 2001
期刊: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
影响因子: --
作者: [Shen,H, Balschi,JA, Pohost,GM, Wolkowicz,P]
通讯作者: Wolkowicz,P
ALTERED SUBSTRATE PREFERENCE IN REPERFUSED HEARTS
ALTERED SUBSTRATE PREFERENCE IN REPERFUSED HEARTS
ALTERED SUBSTRATE PREFERENCE IN REPERFUSED HEARTS
CARNITINE TRANSPORT IN NATURAL AND ARTIFICIAL MEMBRANE
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
  • 批准号:
    61602201
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    周雄辉
  • 依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
  • 批准号:
    81170309
  • 项目类别:
    面上项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2011
  • 负责人:
    颜桥
  • 依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
  • 批准号:
    30672394
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2006
  • 负责人:
    陆豪杰
  • 依托单位: